Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Considers Bulk Buys Of Costly MNC Devices, Drugs

This article was originally published in PharmAsia News

Executive Summary

Indian authorities are considering buying certain medical devices and drugs in volume to ensure they are more affordable to Indians who need them. Under the plan, multinational companies would be barred from having direct access to patients if they have a monopoly over expensive products. Government officials believe the companies also would benefit because they would have a massive contract for their products without the high cost of promoting them. Some drug makers already sell pharmaceuticals in India at prices lower than those they charge in developed countries. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts